
McKinsey Settles Opioid Probe for $650M; Ex-Partner Faces Charges
McKinsey & Co. has agreed to pay $650 million in a deferred prosecution agreement to settle a federal criminal investigation into its consulting work with Purdue Pharma, which involved advising on increasing sales of the opioid OxyContin. Additionally, a former McKinsey partner will plead guilty to obstruction of justice for destroying and concealing documents related to the probe.






